Price
Financials
Consolidated, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8.06 | 10.13 | 11.07 | 12.88 | 11.40 | 12.51 | 10.06 | 8.80 | 12.38 | 19.07 | 21.29 | 18.28 |
| Expenses | 7.46 | 9.12 | 10.09 | 9.65 | 8.90 | 10.44 | 10.44 | 10.58 | 10.31 | 13.84 | 17.00 | 15.33 |
| Operating Profit | 0.60 | 1.01 | 0.98 | 3.23 | 2.50 | 2.07 | -0.38 | -1.78 | 2.07 | 5.23 | 4.29 | 2.95 |
| OPM % | 7.44% | 9.97% | 8.85% | 25.08% | 21.93% | 16.55% | -3.78% | -20.23% | 16.72% | 27.43% | 20.15% | 16.14% |
| Other Income | 0.26 | -0.11 | 0.23 | 0.11 | 0.16 | 0.23 | 0.15 | 0.33 | 0.20 | 0.14 | 0.29 | 0.17 |
| Interest | 0.26 | 0.15 | 0.33 | 0.33 | 0.45 | 0.43 | 0.55 | 0.54 | 0.55 | 0.54 | 0.41 | 0.44 |
| Depreciation | 1.43 | 1.40 | 1.64 | 1.51 | 1.49 | 1.48 | 1.77 | 1.74 | 1.69 | 1.60 | 1.61 | 1.70 |
| Profit before tax | -0.83 | -0.65 | -0.76 | 1.50 | 0.72 | 0.39 | -2.55 | -3.73 | 0.03 | 3.23 | 2.56 | 0.98 |
| Tax % | -25.30% | -24.62% | -3.95% | 31.33% | 65.28% | 89.74% | -50.59% | -13.67% | 66.67% | 25.70% | 28.52% | 11.22% |
| Net Profit | -0.61 | -0.49 | -0.73 | 1.03 | 0.25 | 0.05 | -1.26 | -3.22 | 0.01 | 2.40 | 1.84 | 0.87 |
| EPS in Rs | -0.39 | -0.31 | -0.47 | 0.70 | 0.16 | 0.07 | -0.82 | -1.96 | -0.06 | 0.90 | 0.81 | 0.27 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 17.39 | 18.21 | 20.39 | 26.13 | 23.94 | 46.90 | 67.79 | 36.18 | 39.65 | 46.84 | 61.54 | 71.02 |
| Expenses | 15.59 | 15.01 | 16.96 | 20.27 | 30.02 | 29.41 | 51.02 | 34.82 | 35.01 | 39.37 | 51.74 | 56.48 |
| Operating Profit | 1.80 | 3.20 | 3.43 | 5.86 | -6.08 | 17.49 | 16.77 | 1.36 | 4.64 | 7.47 | 9.80 | 14.54 |
| OPM % | 10.35% | 17.57% | 16.82% | 22.43% | -25.40% | 37.29% | 24.74% | 3.76% | 11.70% | 15.95% | 15.92% | 20.47% |
| Other Income | 0.37 | 0.58 | 0.92 | 1.00 | 2.50 | 2.39 | 5.91 | 1.07 | 0.67 | 0.65 | 0.97 | 0.80 |
| Interest | 1.28 | 1.54 | 1.87 | 2.36 | 3.04 | 2.26 | 0.96 | 1.04 | 0.98 | 1.82 | 2.04 | 1.94 |
| Depreciation | 0.68 | 1.23 | 2.12 | 3.13 | 3.92 | 3.97 | 3.69 | 5.07 | 5.93 | 6.25 | 6.64 | 6.60 |
| Profit before tax | 0.21 | 1.01 | 0.36 | 1.37 | -10.54 | 13.65 | 18.03 | -3.68 | -1.60 | 0.05 | 2.09 | 6.80 |
| Tax % | 104.76% | 10.89% | 69.44% | 18.25% | -18.60% | 13.99% | 33.78% | -16.58% | -17.50% | -20.00% | 50.72% | |
| Net Profit | -0.01 | 0.90 | 0.11 | 1.11 | -8.59 | 11.74 | 11.94 | -3.07 | -1.33 | 0.05 | 1.03 | 5.12 |
| EPS in Rs | -0.02 | 0.97 | 0.10 | 0.73 | -5.61 | 7.67 | 7.80 | -1.97 | -0.84 | 0.08 | 0.58 | 1.92 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 6.52% | 15.38% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 13% | 6% | 19% | 66% | ||
| Compounded Profit Growth | 45% | -37% | 33% | 186% | ||
| Stock Price CAGR | 9% | -3% | 12% | 139% | ||
| Return on Equity | 3% | 2% | 0% | 2% |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.04 | 9.28 | 11.46 | 15.30 | 15.30 | 15.30 | 15.30 | 15.48 | 15.48 | 15.83 | 19.92 |
| Reserves | -2.27 | 7.60 | 10.55 | 16.53 | 7.92 | 19.72 | 35.28 | 32.71 | 32.95 | 34.11 | 52.02 |
| Borrowings | 11.08 | 8.45 | 18.78 | 18.15 | 17.95 | 10.34 | 12.55 | 10.10 | 13.41 | 20.58 | 21.28 |
| Other Liabilities | 5.56 | 5.56 | 8.59 | 11.32 | 12.70 | 20.62 | 14.75 | 7.63 | 6.03 | 7.77 | 13.37 |
| Total Liabilities | 20.41 | 30.89 | 49.38 | 61.30 | 53.87 | 65.98 | 77.88 | 65.92 | 67.87 | 78.29 | 106.59 |
| Fixed Assets | 8.67 | 16.35 | 28.17 | 32.59 | 30.54 | 27.38 | 19.07 | 24.97 | 26.66 | 34.55 | 36.08 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.90 | 2.81 | 4.71 | 4.71 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.98 |
| Other Assets | 11.74 | 14.54 | 21.21 | 28.71 | 23.33 | 38.60 | 58.81 | 39.05 | 38.40 | 39.03 | 62.82 |
| Total Assets | 20.41 | 30.89 | 49.38 | 61.30 | 53.87 | 65.98 | 77.88 | 65.92 | 67.87 | 78.29 | 106.59 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 3.55 | -5.62 | 5.65 | 4.04 | -0.01 | 4.95 | 19.56 | -6.41 | 2.89 | 10.07 | 0.42 |
| Cash from Investing Activity | -3.63 | -8.90 | -14.35 | -7.87 | -1.90 | -0.80 | -1.20 | -6.93 | -11.53 | -15.62 | -9.98 |
| Cash from Financing Activity | 0.23 | 14.57 | 9.86 | 6.08 | 0.44 | -0.13 | 5.67 | -9.54 | 2.35 | 5.24 | 18.83 |
| Net Cash Flow | 0.15 | 0.05 | 1.17 | 2.25 | -1.47 | 4.02 | 24.03 | -22.88 | -6.29 | -0.30 | 9.26 |
| Free Cash Flow | -0.08 | -14.52 | -8.70 | -3.83 | -1.91 | 4.15 | 17.33 | -14.57 | -9.14 | -5.96 | -7.76 |
| CFO/OP | 197% | -176% | 165% | 69% | 32% | 39% | 153% | -269% | 101% | 135% | 5% |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 151.96 | 227.10 | 291.79 | 205.20 | 104.29 | 112.46 | 40.97 | 117.83 | 113.14 | 124.21 | 122.71 |
| Inventory Days | 72.11 | 105.50 | 104.15 | 155.61 | 226.63 | ||||||
| Days Payable | 98.78 | 322.56 | 205.43 | 305.45 | 458.49 | ||||||
| Cash Conversion Cycle | 151.96 | 227.10 | 291.79 | 205.20 | 104.29 | 112.46 | 14.30 | -99.23 | 11.85 | -25.63 | -109.15 |
| Working Capital Days | 52.05 | 90.60 | 35.44 | -3.07 | -100.78 | 37.36 | 10.18 | 110.67 | 137.35 | 128.19 | 121.41 |
| ROCE % | 12.69% | 6.75% | 8.22% | -16.39% | 36.77% | 27.58% | -4.34% | -1.03% | 2.80% | 5.01% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 38.48% | 38.48% | 38.70% | 38.70% | 38.70% | 37.84% | 38.05% | 38.05% | 38.05% | 38.05% | 30.25% | 30.25% |
| Public | 61.51% | 61.51% | 61.29% | 61.29% | 61.31% | 62.17% | 61.96% | 61.96% | 61.95% | 61.96% | 69.75% | 69.76% |
| No. of Shareholders | 5,933 | 5,727 | 5,749 | 5,655 | 5,607 | 5,565 | 5,497 | 5,460 | 5,444 | 5,159 | 5,053 | 4,966 |
Fundamentals
Market Cap₹ 163 Cr.
Current Price₹ 81.0
Stock P/E46.7
Book Value₹ 36.1
ROCE5.01 %
ROE1.89 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)66%
Compounded Profit Growth (TTM)186%
Consolidated figures.
Valuation
Market capRs 170 Cr
Enterprise valueRs 182 Cr
P/E (TTM)48.88x
Price to book2.36x
Price to sales2.40x
EV / EBITDA11.86x
EV / EBIT20.81x
EV / sales2.56x
Price to cash flow405.00x
Earnings yield2.05%
P/E, 3-year average488.42x
P/B, 3-year average1.45x
P/E, 5-year average252.53x
P/B, 5-year average2.10x
Profitability
Operating margin (excl. other income)15.92%
Operating margin (incl. other income)17.50%
EBITDA margin21.60%
Pre-tax margin9.57%
Net profit margin4.90%
Net margin, latest quarter2.95%
ROE1.89%
ROCE5.04%
ROA1.24%
ROE, 3-year average-0.18%
ROCE, 3-year average2.28%
ROA, 3-year average-0.17%
ROE, 5-year average4.24%
ROCE, 5-year average7.50%
ROA, 5-year average2.37%
ROIC (approx.)5.15%
Tax rate50.72%
Other income / net worth1.35%
Growth
Sales growth (latest year)31.38%
Profit growth (latest year)784.62%
Sales CAGR, 3 years19.37%
Sales CAGR, 5 years5.58%
Profit CAGR, 5 years-37.16%
Sales growth QoQ-14.14%
Profit growth QoQ-66.46%
Sales growth YoY (latest quarter)107.73%
Per share
EPS (TTM)Rs 1.73
EPS (latest quarter)Rs 0.27
EPS, 3-year averageRs -0.38
EPS, 5-year averageRs 1.27
Book value per shareRs 35.83
Sales per shareRs 35.37
Cash flow per shareRs 0.21
Free cash flow per shareRs -3.86
Dividend per share, 5-year averageRs 1.20
Dividends
Dividend payout, 5-year average15.41%
Efficiency
Asset turnover0.58x
Fixed asset turnover1.71x
Inventory turnover1.61x
Inventory days227 days
Debtor days123 days
Debtors turnover2.97x
Creditor days458 days
Cash conversion cycle-109 days
Working capital days121 days
Leverage
Total debtRs 21 Cr
Cash and bankRs 10 Cr
Net debtRs 12 Cr
Debt to equity0.30x
Net debt / EBITDA0.77x
Interest coverage4.51x
Owners' fund to total sources67.49%
Debt to assets19.96%
Cash flow
Cash from Operating Activity (latest year)Rs 0 Cr
Cash from Investing Activity (latest year)Rs -10 Cr
Cash from Financing Activity (latest year)Rs 19 Cr
Net Cash Flow (latest year)Rs 9 Cr
Free cash flow (latest year)Rs -8 Cr
FCFE (approx.: FCF + change in debt)Rs -7 Cr
Cash from ops / profit, 5 years3.08x
Sales to cash flow146.52x
Statement figures
Net sales (TTM)Rs 71 Cr
Net sales (latest year)Rs 62 Cr
Sales (latest quarter)Rs 18 Cr
Operating profit excl. other income (latest year)Rs 10 Cr
Operating profit (latest quarter)Rs 3 Cr
Other income (TTM)Rs 1 Cr
EBITDA (TTM)Rs 15 Cr
PBDT (TTM)Rs 13 Cr
Profit before tax (TTM)Rs 7 Cr
Tax (latest year)Rs 1 Cr
Net profit (TTM)Rs 3 Cr
Net profit (latest year)Rs 1 Cr
Net profit (latest quarter)Rs 1 Cr
Depreciation (TTM)Rs 7 Cr
Depreciation (latest quarter)Rs 2 Cr
Interest (TTM)Rs 2 Cr
Cost of goods sold (latest year)Rs 5 Cr
Total expenditure (latest year)Rs 52 Cr
Total income (latest year)Rs 63 Cr
Share capitalRs 20 Cr
ReservesRs 52 Cr
Shareholders' fundsRs 72 Cr
Total assetsRs 107 Cr
Net blockRs 36 Cr
Capital work in progressRs 5 Cr
InvestmentsRs 3 Cr
ReceivablesRs 21 Cr
InventoryRs 3 Cr
Other liabilitiesRs 13 Cr
Shares outstanding (crore)2.01
Ownership
Promoter holding30.25% (-7.80 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 38.5 is at the 67th percentile of its own 4.6-year range
(median 26.0, low 6.5, high 372.8).
P/B 1.86 is at the 43th percentile (median 1.91).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 538837 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | +9.9% | -2.8% | +12.7 pts |
| 1 month | +14.3% | -6.8% | +21.0 pts |
| 3 months | +8.0% | -7.6% | +15.6 pts |
| 3 years | +46.1% | +14.2% | +32.0 pts |
| 5 years | -9.7% | +27.9% | -37.6 pts |
Red flags
F-score 4 of 8| explain | Share dilution Share count up 26% in a year, 28% in three |
| look | Profit leans on other income Other income was 46% of pre-tax profit in 2026 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹18 Cr +107.7% vs Jun 2025.
Net profit ₹1 Cr +127.0%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Syngene International Ltd | 14,823 | 50.0 | 9.99 % |
| Indegene Ltd | 14,580 | 35.0 | 18.8 % |
| Suven Life Sciences Ltd | 9,176 | -79.5 % | |
| Vimta Labs Ltd | 2,642 | 32.7 | 25.2 % |
| Fabtech Technologies Ltd | 661 | 13.6 | 13.6 % |
| Bilcare Ltd | 229 | 11.5 | 7.06 % |
| Take Ltd | 208 | 35.2 | 18.5 % |
| Novelix Pharmaceuticals Ltd | 199 | 55.1 | 10.9 % |
| Adeshwar Meditex Ltd | 24 | 19.4 | 5.21 % |
| Vanta Bioscience Ltd | 15 | 133 | 1.19 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Jeevan Scientific Technology Ltd?
Jeevan Scientific Technology Ltd (538837) has a market capitalisation of Rs 163 Cr. at the 2026-10-01 close.
What is the P/E ratio of Jeevan Scientific Technology Ltd?
Jeevan Scientific Technology Ltd trades at a P/E of 46.7 on trailing twelve-month profit, at the 2026-10-01 close.
What were Jeevan Scientific Technology Ltd's latest quarterly results?
In the Jun 2026 quarter, Jeevan Scientific Technology Ltd sales was Rs 18 Cr (+107.7% vs Jun 2025) and net profit was Rs 1 Cr.